Philippines Seizes $80M in Illegal Vapes Over 10 Months

Nov.19.2024
Philippines Seizes $80M in Illegal Vapes Over 10 Months
The Philippines Bureau of Customs seized approximately $86.5 million worth of vapes during enforcement operations in the first ten months of 2024.

The Philippines Bureau of Customs announced that its ongoing crackdown on smuggled e-cigarette products resulted in the seizure of items valued at $86.5 million during the first ten months of 2024, the Manila Times reported on November 19.

 

Recent operations included the confiscation of disposable vapes worth $220,000 in Laguna province and various e-cigarette devices, pods, and disposable products valued at $110,000 in Quezon City, Manila.

 

"These operations highlight the BOC's unwavering determination to dismantle the illicit networks behind vape smuggling and the continuous strengthening of its enforcement capabilities," Customs Chief Bienvenido Rubio said.

 

He also added that the agency works closely with the Bureau of Internal Revenue (BIR), the Department of Trade and Industry (DTI), and enforcement and intelligence units to do its job.

 

"With the support of enhanced intelligence-sharing, the BOC remains vigilant in addressing emerging trends in illicit trade," Rubio said.

 

Syria announces comprehensive ban on e-cigarettes covering production, trade, sale and use
Syria announces comprehensive ban on e-cigarettes covering production, trade, sale and use
Syria Damascus health authorities announced a comprehensive ban on e-cigarettes, prohibiting their production, circulation, sale and use, citing health risks and the need to protect public health, particularly among children and young people.
Mar.02 by 2FIRSTS.ai
Thai Vape User Numbers Rose More Than 11-Fold in Three Years, Group Says Ban Should Be Reassessed
Thai Vape User Numbers Rose More Than 11-Fold in Three Years, Group Says Ban Should Be Reassessed
A network of e-cigarette users in Thailand has urged the new government to review the country’s vape ban, saying official data show that use has risen sharply despite more than a decade of prohibition.
Mar.27 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
Product | OXVA launches SlimStick X in Europe and the U.S., shifting from pre-filled to open-system refilling
Product | OXVA launches SlimStick X in Europe and the U.S., shifting from pre-filled to open-system refilling
OXVA has recently launched its new e-cigarette, the SlimStick X. Unlike its predecessor, the SlimStick, which used a pre-filled pod system, the SlimStick X adopts an open-system refillable design, featuring a 2ml pod, a 1.0Ω coil, and a 1400mAh battery. The product has entered online retail channels in markets including the United States, the United Kingdom, Greece, and Spain, with a price of about $23.99.
Mar.06 by 2FIRSTS.ai
Malaysia’s Selangor health authorities fine company US$5,000 over toy-like vape devices
Malaysia’s Selangor health authorities fine company US$5,000 over toy-like vape devices
Selangor’s health department said a company was fined RM20,000(US$5,000) for supplying vape devices designed to resemble toys. Officers raided the firm’s premises near Taman Kosas in Ampang on Dec 19, 2025 after discovering it was importing and distributing toy-shaped vape devices.
Mar.05 by 2FIRSTS.ai
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11